Re: Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (177Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate Cancer

Samir S. Taneja

doi:10.1097/JU.0000000000000779.01

Re: Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (¹⁷⁷Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate Cancer

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	The Journal of urology
Volume	203
Issue number	5
DOIs	https://doi.org/10.1097/JU.0000000000000779.01
State	Published - May 1 2020

ASJC Scopus subject areas

Urology

Access to Document

10.1097/JU.0000000000000779.01

Cite this

@article{a43f64dba8554e9eb111abc664a6a5e3,

title = "Re: Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (177Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate Cancer",

author = "Taneja, {Samir S.}",

year = "2020",

month = may,

day = "1",

doi = "10.1097/JU.0000000000000779.01",

language = "English (US)",

volume = "203",

journal = "The Journal of urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Re

T2 - Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (177Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate Cancer

AU - Taneja, Samir S.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85086053040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086053040&partnerID=8YFLogxK

U2 - 10.1097/JU.0000000000000779.01

DO - 10.1097/JU.0000000000000779.01

M3 - Comment/debate

C2 - 32073970

AN - SCOPUS:85086053040

SN - 0022-5347

VL - 203

JO - The Journal of urology

JF - The Journal of urology

IS - 5

ER -

Re: Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (177Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Re: Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (¹⁷⁷Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate Cancer